Prevalence of cognitive impairment and its predictors among chronic kidney disease patients: A systematic review and meta-analysis
PLOS ONE · 03.06.2024 · 19 (6) · e0304762
DOI: 10.1371/journal.pone.0304762 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 03.06.2024. Verfasst von Jialing Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Cognitive Dysfunction. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xuanwu Hospital Huizhi talent leader training program.
Abstract (Originalsprache)
Background
Cognitive impairment (CI) is common among patients with chronic kidney disease (CKD), and is associated with a poor prognosis. We assessed the prevalence and associated factors of CI in patients with CKD.
Methods
A systematic review and meta-analysis were conducted by searching PubMed, Embase, and the Web of Science through December 1, 2023. Random effects models were performed with subgroup analyses to further explore the heterogeneity.
Results
50 studies involving 25,289 CKD patients were included. The overall prevalence of CI was 40% (95% confidence interval 33–46). The pooled prevalence of CI was relatively higher in CKD patients from Africa (58%), Asia (44%) and America (37%). Attention and executive dysfunction appeared to be the most common manifestations. The prevalence of CI was higher among patients with hemodialysis (53%) and peritoneal dialysis (39%) than those without dialysis (32%) and post-kidney transplanted (26%). In addition, advanced age, the presence of diabetes and hypertension might increase the risk of CI in CKD patients.
Conclusions
People with CKD have a high prevalence of CI, especially in patients with hemodialysis. An early and comprehensive screening for CI in CKD patients is needed to improve clinical outcomes.
Trial registration
Registration number: PROSPERO ( CRD42023412864 )
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Nephrology, Xuanwu Hospital, Capital Medical University, Beijing, China.
- The National Clinical Research Center for Geriatric Disease, Xuanwu Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Aihua Zhang
Förderung
- Xuanwu Hospital Huizhi talent leader training program
Zitieren
APA
Zhang, J., Wu, L., Wang, P., Pan, Y., Dong, X., Jia, L., & Zhang, A. (2024). Prevalence of cognitive impairment and its predictors among chronic kidney disease patients: A systematic review and meta-analysis. PLOS ONE, 19(6), e0304762. https://doi.org/10.1371/journal.pone.0304762
Vancouver
Zhang J, Wu L, Wang P, Pan Y, Dong X, Jia L, et al. Prevalence of cognitive impairment and its predictors among chronic kidney disease patients: A systematic review and meta-analysis. PLOS ONE. 2024;19(6):e0304762. doi:10.1371/journal.pone.0304762
BibTeX
@article{Zhang2024,
author = {Zhang, Jialing and Wu, Leiyun and Wang, Peixin and Pan, Yajing and Dong, Xingtong and Jia, Linpei and Zhang, Aihua},
title = {Prevalence of cognitive impairment and its predictors among chronic kidney disease patients: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {6},
pages = {e0304762},
doi = {10.1371/journal.pone.0304762}
}
EUVIMED